Adverum Biotechnologies Initiates ARTEMIS Phase 3 Study Evaluating Ixo-vec for Wet AMD
Ixo-vec is a potential best-in-class one-time gene therapy designed to deliver long-term efficacy, reduce the burden of frequent anti-VEGF and ...
Medscape11h
Hemophilia A: Gene Therapy a Game Changer
“Gene therapy for hemophilia A with the use of lentiviral vector-transduced autologous HSCs resulted in stable factor VIII expression, with factor VIII activity correlating to vector copy number in ...
manilatimes4d
Pacira BioSciences Acquires Remaining Equity Stake of GQ Bio
Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to deliver innovative, non-opioid pain ...
OXB to present at the Leerink Partners Global Healthcare Conference
OXB to present at the Leerink Partners Global Healthcare Conference Oxford, UK – 26 February 2025: OXB (LSE: OXB), a global ...
BioWorld5d
Restoring GJB2 expression rescues hereditary hearing loss
The most common form of hereditary deafness in humans is caused by mutations in the GJB2 gene, which encodes the gap junction protein connexin 26. That regulates the transport of potassium and ...
Taiwan News7d
Viral Vector Market to Surpass USD 3.10 Billion, Projected 11.5%+ CAGR Through 2030
The Global Viral Vector Market was valued at approximately USD 3.10 billion in 2022 and is projected to grow at a robust CAGR of more than 11.5% during the forecast period 2023-2030. Read the Market ...
Business Insider11d
Boehringer Ingelheim and partners start clinical development of a first-in-class, inhaled gene therapy for people with cystic fibrosis
One of the original pioneers in cell and gene therapy, OXB has more than 25 years of experience ... adeno-associated virus (AAV), adenovirus, and other viral vector types. OXB’s world-class ...
Viral Vector And Plasmid DNA Manufacturing Market size to Show Positive Growth at a CAGR of 20.4% by 2034
The global viral vector and plasmid DNA manufacturing market size is calculated at USD 8.66 billion in 2025 and is expected ...
News Medical13d
Gene therapy breakthrough offers hope for severe Dravet syndrome cases
AAV-Navβ1 gene therapy effectively reduces seizures and prolongs life in a mouse model of SCN1B-linked Dravet syndrome, ...
DeFiance on MSN13d
AAV Innovation Summit 2025 to Explore AI and Vector Design in Gene Therapy
The AAV Innovation Summit 2025, hosted by Form Bio, will bring together top experts in gene therapy to discuss the latest advancements in adeno-associated virus (AAV) therapeutics. The event, set for ...
ThePrint13d
JAIN University Launches Bachelor’s in Occupational Therapy for Aspiring Healthcare Professionals
Bengaluru (Karnataka) [India], February 17: JAIN (Deemed-to-be University), a leader in innovative education, has launched the Bachelor’s in Occupational Therapy (BOT) program at its School of Allied ...
CNN14d
What a $2 million per dose gene therapy reveals about drug pricing
he said he became convinced that Kaspar’s gene therapy was the answer. Carbona remade BioLife into AveXis: Av for adeno-associated virus serotype 9, the engine of Kaspar’s drug; ve for vector ...